Association of NAT2 Gene Polymorphisms with Susceptibility to Esophageal and Gastric Cancers in the Kashmir Valley

Archives of Medical Research

Volumn 40, Issue 5, 2009, Pages 416-423

  Malik, Manzoor Ahmad ^a   Upadhyay, Rohit ^a   Modi, Dinesh Raj ^b   Zargar, Showket Ali ^c   Mittal, Balraj ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b BABASAHEB BHIMRAO AMBEDKAR UNIVERSITY   (India)

^c SHER I KASHMIR INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Esophageal and gastric cancers; Genetic susceptibility; Haplotypes; Kashmir valley; N Acetyltransferases

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE;

ADULT; ARTICLE; CANCER RISK; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; FEMALE; FOOD INTAKE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; RISK FACTOR; SMOKING; STOMACH CANCER;

AGED; ALLELES; ARYLAMINE N-ACETYLTRANSFERASE; CASE-CONTROL STUDIES; ESOPHAGEAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INDIA; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; STOMACH NEOPLASMS;

EID: 70349089654     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2009.06.009     Document Type: Article

References (42)

1. Khuroo M.S., Zargar S.A., Mahajan R., et al. High incidence of oesophageal and gastric cancer in Kashmir in a population with special personal and dietary habits. Gut 33 (1992) 11-15
2. Taningher M., Malacarne D., Izzotti A., et al. Drug metabolism polymorphisms as modulators of cancer susceptibility. Mutat Res 436 (1999) 227-261
3. Hickman D., Pope J., Patil S.D., et al. Expression of arylamine N-acetyltransferase in human intestine. Gut 42 (1998) 402-409
4. Husain A., Zhang X., Doll M.A., et al. Identification of N-acetyltransferase 2 (NAT2) transcription start sites and quantitation of NAT2-specific mRNA in human tissues. Drug Metab Dispos 35 (2007) 721-727
5. Blum M., Grant D.M., McBride W., et al. Human arylamine N-acetyltransferase genes: isolation, chromosomal localization, and functional expression. DNA Cell Biol 9 (1990) 193-203
6. http://louisville.edu/medschool/pharmacology/NAT.html. May 27, 2008.
7. Cascorbi I., and Roots I. Pitfalls in N-acetyltransferase 2 genotyping. Pharmacogenetics 9 (1999) 123-127
8. Deitz A.C., Rothman N., Rebbeck T.R., et al. Impact of misclassification in genotype-exposure interaction studies: example of N-acetyltransferase 2 (NAT2), smoking, and bladder cancer. Cancer Epidemiol Biomarkers Prev 13 (2004) 1543-1546
9. Kilbane A.J., Silbart L.K., Manis M., et al. Human N-acetylation genotype determination with urinary caffeine metabolites. Clin Pharmacol Ther 47 (1990) 470-477
10. Parkin D.P., Vandenplas S., Botha F.J., et al. Trimodality of isoniazid elimination: phenotype and genotype in patients with tuberculosis. Am J Respir Crit Care Med 155 (1997) 1717-1722
11. Mitchell K.R., and Warshawsky D. Xenobiotic inducible regions of the human arylamine N-acetyltransferase 1 and 2 genes. Toxicol Lett 139 (2003) 11-23
12. Garte S., Gaspari L., Alexandrie A.K., et al. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev 10 (2001) 1239-1248
13. Siddiqi M., Kumar R., Fazili Z., et al. Increased exposure to dietary amines and nitrate in a population at high risk of oesophageal and gastric cancer in Kashmir (India). Carcinogenesis 13 (1992) 1331-1335
14. Correa P. Modulation of gastric carcinogenesis: updated model based on intragastric nitrosation. IARC Sci Publ (1987) 485-491
15. Kumar R., Mende P., Wacker C.D., et al. Caffeine-derived N-nitroso compounds-I: nitrosatable precursors from caffeine and their potential relevance in the etiology of oesophageal and gastric cancers in Kashmir, India. Carcinogenesis 13 (1992) 2179-2782
16. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16 (1988) 1215
17. Bell D.A., Taylor J.A., Butler M.A., et al. Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans. Carcinogenesis 14 (1993) 1689-1692
18. Gauderman WJ. QUANTO 1.1: A computer program for power and sample size calculations for genetic-epidemiology studies. http://hydrauscedu/gxe 2006.
19. Pandey S.N., Modi D.R., Choudhuri G., et al. Slow acetylator genotype of N-acetyl transferase2 (NAT2) is associated with increased susceptibility to gallbladder cancer: the cancer risk not modulated by gallstone disease. Cancer Biol Ther 6 (2007) 91-96
20. Jain M., Kumar S., Lal P., et al. Association of genetic polymorphisms of N-acetyltransferase 2 and susceptibility to esophageal cancer in north Indian population. Cancer Invest 25 (2007) 340-346
21. Srivastava D.S., and Mittal R.D. Genetic polymorphism of the N-acetyltransferase 2 gene, and susceptibility to prostate cancer: a pilot study in north Indian population. BMC Urol 5 (2005) 12
22. Mittal R.D., Srivastava D.S., and Mandhani A. NAT2 gene polymorphism in bladder cancer: a study from North India. Int Braz J Urol 30 (2004) 279-285 discussion 285-288
23. Anitha A., and Banerjee M. Arylamine N-acetyltransferase 2 polymorphism in the ethnic populations of South India. Int J Mol Med 11 (2003) 125-131
24. Babu K.A., Rao K.L., Reddy N.G., et al. N-acetyl transferase 2 polymorphism and advanced stages of endometriosis in South Indian women. Reprod Biomed Online 9 (2004) 533-540
25. Majumdar S., Mondal B.C., Ghosh M., et al. Association of cytochrome P450, glutathione S-transferase and N-acetyl transferase 2 gene polymorphisms with incidence of acute myeloid leukemia. Eur J Cancer Prev 17 (2008) 125-132
26. Garcia-Martin E. Interethnic and intraethnic variability of NAT2 single nucleotide polymorphisms. Curr Drug Metab 9 (2008) 487-497
27. Zhou W., Liu G., Thurston S.W., et al. Genetic polymorphisms in N-acetyltransferase-2 and microsomal epoxide hydrolase, cumulative cigarette smoking, and lung cancer. Cancer Epidemiol Biomarkers Prev 11 (2002) 15-21
28. Ohsako S., and Deguchi T. Cloning and expression of cDNAs for polymorphic and monomorphic arylamine N-acetyltransferases from human liver. J Biol Chem 265 (1990) 4630-4634
29. Vatsis K.P., Martell K.J., and Weber W.W. Diverse point mutations in the human gene for polymorphic N-acetyltransferase. Proc Natl Acad Sci USA 88 (1991) 6333-6337
30. Cascorbi I., Drakoulis N., Brockmoller J., et al. Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: correlation with phenotypic activity. Am J Hum Genet 57 (1995) 581-592
31. Morita S., Yano M., Tsujinaka T., et al. Association between genetic polymorphisms of glutathione S-transferase P1 and N-acetyltransferase 2 and susceptibility to squamous-cell carcinoma of the esophagus. Int J Cancer 79 (1998) 517-520
32. Shibuta J., Eto T., Kataoka A., et al. Genetic polymorphism of N-acetyltransferase 2 in patients with esophageal cancer. Am J Gastroenterol 96 (2001) 3419-3424
33. Lee J.M., Lee Y.C., Yang S.Y., et al. Genetic polymorphisms of p53 and GSTP1, but not NAT2, are associated with susceptibility to squamous-cell carcinoma of the esophagus. Int J Cancer 89 (2000) 458-464
34. Windmill K.F., Gaedigk A., Hall P.M., et al. Localization of N-acetyltransferases NAT1 and NAT2 in human tissues. Toxicol Sci 54 (2000) 19-29
35. Boissy R.J., Watson M.A., Umbach D.M., et al. A pilot study investigating the role of NAT1 and NAT2 polymorphisms in gastric adenocarcinoma. Int J Cancer 87 (2000) 507-511
36. Katoh T., Boissy R., Nagata N., et al. Inherited polymorphism in the N-acetyltransferase 1 (NAT1) and 2 (NAT2) genes and susceptibility to gastric and colorectal adenocarcinoma. Int J Cancer 85 (2000) 46-49
37. Ladero J.M., Agundez J.A., Olivera M., et al. N-acetyltransferase 2 single-nucleotide polymorphisms and risk of gastric carcinoma. Eur J Clin Pharmacol 58 (2002) 115-118
38. Lan Q., Rothman N., Chow W.H., et al. No apparent association between NAT1 and NAT2 genotypes and risk of stomach cancer. Cancer Epidemiol Biomarkers Prev 12 (2003) 384-386
39. Suzuki S., Muroishi Y., Nakanishi I., et al. Relationship between genetic polymorphisms of drug-metabolizing enzymes (CYP1A1, CYP2E1, GSTM1, and NAT2), drinking habits, histological subtypes, and p53 gene point mutations in Japanese patients with gastric cancer. J Gastroenterol 39 (2004) 220-230
40. Marcus P.M., Vineis P., and Rothman N. NAT2 slow acetylation and bladder cancer risk: a meta-analysis of 22 case-control studies conducted in the general population. Pharmacogenetics 10 (2000) 115-122
41. Ghadirian P. Thermal irritation and esophageal cancer in northern Iran. Cancer 60 (1987) 1909-1914
42. Siddiqi M., Tricker A.R., and Preussmann R. Formation of N-nitroso compounds under simulated gastric conditions from Kashmir foodstuffs. Cancer Lett 39 (1988) 259-265